Ardsley Advisory Partners’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-650,000	Closed	-$4.01M	–	176
2019 Q2	$4.01M	Sell	650,000 -605,000	-48%	-$3.73M	0.63%	30
2019 Q1	$5.82M	Buy	1,255,000 +727,900	+138%	+$3.38M	1.12%	26
2018 Q4	$2.21M	Sell	527,100 -1,517,900	-74%	-$6.38M	0.56%	32
2018 Q3	$12.8M	Sell	2,045,000 -85,000	-4%	-$533K	1.73%	15
2018 Q2	$17.1M	Hold	2,130,000	–	–	2.58%	10
2018 Q1	$15.9M	Buy	2,130,000 +300,000	+16%	+$2.24M	2.38%	13
2017 Q4	$10.9M	Sell	1,830,000 -80,000	-4%	-$476K	1.32%	17
2017 Q3	$14.1M	Buy	1,910,000 +1,400,000	+275%	+$10.3M	1.87%	9
2017 Q2	$3.46M	Buy	510,000 +131,500	+35%	+$892K	0.54%	44
2017 Q1	$3.57M	Buy	378,500 +108,500	+40%	+$1.02M	0.56%	46
2016 Q4	$2.33M	Sell	270,000 -190,000	-41%	-$1.64M	0.39%	55
2016 Q3	$2.91M	Buy	460,000 +60,000	+15%	+$380K	0.46%	49
2016 Q2	$1.69M	Buy	+400,000	New	+$1.69M	0.29%	53